Form 8-K - Current report:
SEC Accession No. 0001104659-24-087261
Filing Date
2024-08-08
Accepted
2024-08-08 16:06:19
Documents
16
Period of Report
2024-08-08
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421124d2_8k.htm   iXBRL 8-K 32997
2 EXHIBIT 3.1 tm2421124d2_ex3-1.htm EX-3.1 7564
3 EXHIBIT 99.1 tm2421124d2_ex99-1.htm EX-99.1 7181
7 GRAPHIC tm2421124d2_ex3-1img001.jpg GRAPHIC 8536
  Complete submission text file 0001104659-24-087261.txt   242471

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA trvn-20240808.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvn-20240808_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvn-20240808_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2421124d2_8k_htm.xml XML 3792
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36193 | Film No.: 241188213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)